Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mechanisms of drug combinations: interaction and network perspectives.

Literature DB >> 19180105

Mechanisms of drug combinations: interaction and network perspectives.

Jia Jia¹, Feng Zhu, Xiaohua Ma, Zhiwei Cao, Zhiwei W Cao, Yixue Li, Yixue X Li, Yu Zong Chen.

Abstract

Understanding the molecular mechanisms underlying synergistic, potentiative and antagonistic effects of drug combinations could facilitate the discovery of novel efficacious combinations and multi-targeted agents. In this article, we describe an extensive investigation of the published literature on drug combinations for which the combination effect has been evaluated by rigorous analysis methods and for which relevant molecular interaction profiles of the drugs involved are available. Analysis of the 117 drug combinations identified reveals general and specific modes of action, and highlights the potential value of molecular interaction profiles in the discovery of novel multicomponent therapies.

Mesh：

Year: 2009 PMID： 19180105 DOI： 10.1038/nrd2683

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

257 in total

1. Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation.

Authors: Marzia Pennati; Allyson J Campbell; Maria Curto; Mara Binda; Yuzhu Cheng; Lan-Zeng Wang; Nicola Curtin; Bernard T Golding; Roger J Griffin; Ian R Hardcastle; Andrew Henderson; Nadia Zaffaroni; David R Newell
Journal: Mol Cancer Ther Date: 2005-09 Impact factor: 6.261

2. Identification and hydropathic characterization of structural features affecting sequence specificity for doxorubicin intercalation into DNA double-stranded polynucleotides.

Authors: G E Kellogg; J N Scarsdale; F A Fornari
Journal: Nucleic Acids Res Date: 1998-10-15 Impact factor: 16.971

3. 5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction.

Authors: Xiao-Xin Sun; Mu-Shui Dai; Hua Lu
Journal: J Biol Chem Date: 2007-01-22 Impact factor: 5.157

4. Singly-linked catenation and knotting of cisplatin-DNA adduct by DNA topoisomerase I.

Authors: S Kobayashi; M Furukawa; H Hamajima; T Arai; Y Ishii; S Tobinaga; A Tanaka
Journal: Nucleic Acids Symp Ser Date: 1993

Review 5. Apoptosome dysfunction in human cancer.

Authors: K M Hajra; J R Liu
Journal: Apoptosis Date: 2004-11 Impact factor: 4.677

6. Long-acting beta2-adrenergic formoterol and salmeterol induce the apoptosis of B-chronic lymphocytic leukaemia cells.

Authors: Maria Mamani-Matsuda; Daniel Moynet; Mathieu Molimard; Hélène Ferry-Dumazet; Gérald Marit; Josy Reiffers; M Djavad Mossalayi; M Diavad Mossalayi
Journal: Br J Haematol Date: 2004-01 Impact factor: 6.998

Review 7. Evidence of involvement of central neural mechanisms in generating fibromyalgia pain.

Authors: Roland Staud
Journal: Curr Rheumatol Rep Date: 2002-08 Impact factor: 4.592

8. Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone).

Authors: D Voeller; J Kovacs; V Andrawis; E Chu; H Masur; C Allegra
Journal: J Infect Dis Date: 1994-02 Impact factor: 5.226

9. Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin.

Authors: Daiane S Alves; Laura Pérez-Fons; Amparo Estepa; Vicente Micol
Journal: Biochem Pharmacol Date: 2004-08-01 Impact factor: 5.858

10. Celecoxib inhibits interleukin-12 alphabeta and beta2 folding and secretion by a novel COX2-independent mechanism involving chaperones of the endoplasmic reticulum.

Authors: Iraide Alloza; Andy Baxter; Qian Chen; Rune Matthiesen; Koen Vandenbroeck
Journal: Mol Pharmacol Date: 2006-02-07 Impact factor: 4.436

287 in total

1. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy.

Authors: Nagesh Kolishetti; Shanta Dhar; Pedro M Valencia; Lucy Q Lin; Rohit Karnik; Stephen J Lippard; Robert Langer; Omid C Farokhzad
Journal: Proc Natl Acad Sci U S A Date: 2010-10-04 Impact factor: 11.205

2. Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine.

Authors: Shanta Raj Bhattarai; Elayaraja Muthuswamy; Amit Wani; Michal Brichacek; Antonio L Castañeda; Stephanie L Brock; David Oupicky
Journal: Pharm Res Date: 2010-08-21 Impact factor: 4.200

3. Drug discovery: engineering drug combinations.

Authors: Scott J Dixon; Brent R Stockwell
Journal: Nat Chem Biol Date: 2010-05 Impact factor: 15.040

4. Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.

Authors: Sang-Min Lee; Thomas V O'Halloran; SonBinh T Nguyen
Journal: J Am Chem Soc Date: 2010-11-15 Impact factor: 15.419

Review 5. The changing landscape of phase I trials in oncology.

Authors: Kit Man Wong; Anna Capasso; S Gail Eckhardt
Journal: Nat Rev Clin Oncol Date: 2015-11-10 Impact factor: 66.675

6. Optimization of drug combinations using Feedback System Control.

Authors: Patrycja Nowak-Sliwinska; Andrea Weiss; Xianting Ding; Paul J Dyson; Hubert van den Bergh; Arjan W Griffioen; Chih-Ming Ho
Journal: Nat Protoc Date: 2016-01-14 Impact factor: 13.491

7. Diverse Allyl Glucosinolate Catabolites Independently Influence Root Growth and Development.

Authors: Ella Katz; Rammyani Bagchi; Verena Jeschke; Alycia R M Rasmussen; Aleshia Hopper; Meike Burow; Mark Estelle; Daniel J Kliebenstein
Journal: Plant Physiol Date: 2020-04-22 Impact factor: 8.340

8. Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models.

Authors: Jing Tian; Yuanzeng Min; Zachary Rodgers; Kin Man Au; C Tilden Hagan; Maofan Zhang; Kyle Roche; Feifei Yang; Kyle Wagner; Andrew Z Wang
Journal: J Mater Chem B Date: 2017-07-05 Impact factor: 6.331

9. Targeted delivery of platinum-taxane combination therapy in ovarian cancer.

Authors: Swapnil S Desale; Kruti S Soni; Svetlana Romanova; Samuel M Cohen; Tatiana K Bronich
Journal: J Control Release Date: 2015-09-14 Impact factor: 9.776

10. Folate-Mediated Targeted Delivery of Combination Chemotherapeutics Loaded Reduced Graphene Oxide for Synergistic Chemo-Photothermal Therapy of Cancers.

Authors: Raj Kumar Thapa; Yongjoo Choi; Jee-Heon Jeong; Yu Seok Youn; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal: Pharm Res Date: 2016-08-29 Impact factor: 4.200